The Bio Report
Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Episodes (1239)
Extending the Life of Transplanted Kidneys
The Bio Report
Overcoming Antimicrobial Resistance
The Bio Report
Using Targeted Radiotherapies to Treat Challenging CNS Cancers
The Bio Report
Hitting Previously Undruggable Targets with Oral Therapies
The Bio Report
Building Better Models of Human Diseases to Speed Drug Development
The Bio Report
Preventing Opioids from Countering the Benefits of Cancer Immunotherapies
The Bio Report
Better Living through Computational Chemistry
The Bio Report
Outsmarting a Clever One
The Bio Report
The Search for a New Approach to Male Contraception
The Bio Report
Crafting a One-and-Done Epigenetic Editor to Tackle Hepatitis B
The Bio Report
Fueling AI Drug Development with Patient Biology
The Bio Report
The Search for Better Obesity Treatments
The Bio Report
A Novel Approach to Treating Chronic Low Back Pain
The Bio Report
A Biologic Designed to Treat Acute Exacerbations of Asthma and COPD
The Bio Report
Turbocharging Drug Discovery with Health Data
The Bio Report
Revolutionizing the Production of Biologics with Algae
The Bio Report
Making Medicines for a World of People with Cancer
The Bio Report
Harnessing Myeloid Cells to Attack Cancer
The Bio Report
Drawing Lessons from the COVID Pandemic
The Bio Report
A Bet that Myostatins Can Muscle Out Obesity
The Bio Report
Making Whole-Eye Transplantation a Reality
The Bio Report
Synbio Companies Come to Grips with the One “Omic” that Matters
The Bio Report
Searching for Safer Pain Medications
The Bio Report
Bridging the Translational Divide in Healthcare AI
The Bio Report
Seeking Long-Term Pain Relief from a Drug-Free Injection
The Bio Report
Engaging Hard-to-Target Receptors with Antibodies that Activate
The Bio Report
An Insider’s View of the Patent Fights that Shaped the Biotech Industry
The Bio Report
Restoring Balance to the Immune System in Allergic Diseases
The Bio Report
Turning Natural Killers into Off-the-Shelf Therapies for Autoimmune Disease
The Bio Report
Combining an Antibody and siRNA to Treat Hepatitis B
The Bio Report
Looking at the Promise of GLP-1 Agonists Beyond Obesity
The Bio Report
An Off-the-Shelf Cancer Vaccine Faces a Final Clinical Hurdle in NSCLC
The Bio Report
A Nose for Attacking Brain Cancer
The Bio Report
An Unnatural Approach to Undruggable Targets
The Bio Report
Expanding the Drug Developer’s Chemical Universe
The Bio Report
Take 100 Megabytes a Day and Call Me in the Morning
The Bio Report
Extracting the Benefits of Psychedelics
The Bio Report
A Magellan that Circumnavigates Active Binding Sites
The Bio Report
A Very Meh-Ry Biotech Year and What’s Ahead in 2025
The Bio Report
Using Light to Biomanufacture a Steak
The Bio Report
Sit, Stay, and Heal: Bringing Precision Medicine to Dogs, then Humans
The Bio Report
Targeting the Undruggable Proteome
The Bio Report
Preventing a Deadly Disease by Detecting It Before It Becomes Cancer
The Bio Report
Getting Tumors to Say “Eat Me”
The Bio Report
Targeting the Dark Matter of the Genome to Treat Diseases
The Bio Report
Using AI to Discover Small Molecule Alternatives to Biologics
The Bio Report
A BET on a Novel Approach to Treat Autoimmune Conditions
The Bio Report
Cell Therapies that Can Do a Solid for People with Cancer
The Bio Report
Going to Extremes to Discover New Drugs
The Bio Report
Targeting Senescent Cells to Treat Aging-Related Diseases
The Bio Report